Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Prokinetic agents disclosed by Zeria

Jan. 16, 1997

HemoCleanse licenses bioartificial liver technology from Monsanto

Jan. 14, 1997

OXIS files IND for BXT-51072

Jan. 13, 1997

VIMRxyn enters clinical testing in HCV-infected patients

Jan. 9, 1997

ISIS-2302 update

Jan. 9, 1997

Oxis International completes phase I testing of IBD treatment

Jan. 8, 1997

Anti-HCV agents revealed by Japanese and Chinese investigators

Jan. 8, 1997

Prokinetic agents from Tokyo Tanabe

Jan. 8, 1997

Shin Nippon discloses antiulcer agents

Jan. 7, 1997

Lansoprazole equieffective to omeprazole in Dutch trial

Jan. 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 18, 2025.
An early stage 85% remissions rate in AML drives Aptevo’s stock surge
BioWorld
An 85% remissions rate was found in updated results from Aptevo Therapeutics Inc.’s ongoing phase Ib/II Ranier study of mipletamig in one of the toughest blood...
BIO 2025: Makary lays out FDA’s path, launches pilot review program
BioWorld
On the same day that FDA Commissioner Martin Makary spoke in a fireside chat during the 2025 Biotechnology Innovation Organization’s International Convention, the...
Alphadesign: AI creating proteins from scratch
BioWorld Science
The Alphafold machine learning system for predicting a protein’s structure from its amino acid sequence has been adapted to make it possible to design de novo...